Why Kura Oncology Is Skyrocketing Today [The Motley Fool]
Kura Oncology, Inc. (KURA)
Last kura oncology, inc. earnings: 2/25 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.kuraoncology.com/investor-relations
Company Research
Source: The Motley Fool
What happenedShares ofKura Oncology(NASDAQ:KURAThe company did not report any news, but its stock is probably riding the wave ofSyndax PharmaceuticalsNASDAQ:SNDXshares are up by more than 50%So whatOne of Syndax's pipeline candidates is SNDX-563, a potential treatment for leukemia. SNDX-563 works by preventing the interaction between two proteins called menin and MLL, which play a central role in the growth of certain types of leukemia cells. Syndax released data from a phase clinical trial for SNDX-563 on Monday, saying that the data provided "the first clinical evidence that disrupting the interaction between menin and MLL with our potent and selective inhibitor, SNDX-563, can induce response in patients with genetically defined acute leukemias."Image source: Getty Images.Kura Oncology also has an investigational treatment for leukemia in its pipeline, KO-539, which works the same way SNDX-563 does, by blocking the interaction between menin and MLL. KO-539 is currently in a phase /
Show less
Read more
Impact Snapshot
Event Time:
KURA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KURA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KURA alerts
High impacting Kura Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
KURA
News
- Kura Oncology (KURA) had its price target lowered by Wedbush from $38.00 to $36.00. They now have an "outperform" rating on the stock.MarketBeat
- Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Kura Oncology Inc (KURA) Q4 2025 Earnings Call Highlights: KOMZIFTI Launch Boosts Revenue Amid ... [Yahoo! Finance]Yahoo! Finance
- Kura Oncology Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Kura Oncology, Inc. (KURA) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
KURA
Earnings
- 3/5/26 - Miss
KURA
Sec Filings
- 3/5/26 - Form 10-K
- 3/5/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- KURA's page on the SEC website